esRAGE-expressing oHSV enhances anti-tumor efficacy by inhibition of endothelial cell activationJessica Swanner, Ji Young Yoo(The University of Texas Health Science Center at Houston)Molecular Therapy — OncolyticsJanuary 16, 202310.1016/j.omto.2023.01.003Cited by 8SaveCiteExport RISWatch citationsRelated PapersMicroRNA-138 Increases Chemo-Sensitivity of Glioblastoma through Downregulation of Survivin|Biomedicines|2021|12